Financials Eutilex.Co.,Ltd

Equities

A263050

KR7263050007

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 30/05/2024 BST 5-day change 1st Jan Change
2,105 KRW -0.24% Intraday chart for Eutilex.Co.,Ltd +1.94% -37.72%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 631,931 491,644 566,198 345,966 244,105 124,245
Enterprise Value (EV) 1 574,284 460,341 522,763 298,494 184,866 91,085
P/E ratio -43 x -28.6 x -19.5 x -11.7 x -5.84 x -4.48 x
Yield - - - - - -
Capitalization / Revenue 1,572 x 1,202 x 278 x 4,704 x 1,132 x 944 x
EV / Revenue 1,428 x 1,126 x 257 x 4,059 x 857 x 692 x
EV / EBITDA -46.8 x -28.1 x -23.1 x -9.85 x -5.63 x -3.51 x
EV / FCF -66.2 x -20 x 260 x -9.95 x -5.81 x -5.87 x
FCF Yield -1.51% -5% 0.38% -10.1% -17.2% -17%
Price to Book 8.15 x 7.83 x 9.73 x 5.11 x 2.78 x 2.06 x
Nbr of stocks (in thousands) 21,791 21,916 22,588 23,219 36,763 36,759
Reference price 2 29,000 22,433 25,067 14,900 6,640 3,380
Announcement Date 28/03/19 19/03/20 23/03/21 23/03/22 15/03/23 21/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 402 408.9 2,036 73.54 215.7 131.7
EBITDA 1 -12,263 -16,397 -22,591 -30,297 -32,815 -25,959
EBIT 1 -13,728 -18,335 -24,888 -33,560 -36,733 -29,784
Operating Margin -3,414.59% -4,484.32% -1,222.23% -45,632.96% -17,032.78% -22,622.84%
Earnings before Tax (EBT) 1 -13,233 -17,131 -28,768 -29,575 -34,470 -28,342
Net income 1 -13,233 -17,131 -28,768 -29,257 -33,427 -27,718
Net margin -3,291.6% -4,189.82% -1,412.78% -39,782.05% -15,499.53% -21,054.04%
EPS 2 -673.9 -783.7 -1,286 -1,273 -1,137 -754.1
Free Cash Flow 1 -8,680 -23,028 2,009 -30,011 -31,797 -15,506
FCF margin -2,159.04% -5,631.96% 98.67% -40,807.94% -14,744.09% -11,777.71%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 28/03/19 19/03/20 23/03/21 23/03/22 15/03/23 21/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 57,647 31,303 43,435 47,473 59,240 33,160
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -8,680 -23,028 2,009 -30,011 -31,797 -15,506
ROE (net income / shareholders' equity) -20.6% -24.4% -47.4% -45.3% -42.3% -36.8%
ROA (Net income/ Total Assets) -12% -14.2% -17.1% -19.1% -21% -21%
Assets 1 110,705 120,397 167,880 152,891 158,808 131,905
Book Value Per Share 2 3,556 2,867 2,576 2,916 2,386 1,644
Cash Flow per Share 2 1,551 310.0 1,359 1,303 1,083 825.0
Capex 1 3,037 13,115 5,657 5,048 1,826 100
Capex / Sales 755.4% 3,207.62% 277.79% 6,863.53% 846.87% 76.28%
Announcement Date 28/03/19 19/03/20 23/03/21 23/03/22 15/03/23 21/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A263050 Stock
  4. Financials Eutilex.Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW